Safety and Efficacy of an Intravaginal Prebiotic Gel in the Prevention of Recurrent Bacterial Vaginosis: A Randomized Double-Blind Study

Table 3

Percentage of pathogenic germs in active and placebo groups.

		D0		D8		D16
		Active	Placebo	Active	Placebo	Active	Placebo
Candida albicans	Absence	85	91	85	77	90	86
	Presence	5	5	5	18	0	9
Gardnerella morphotype	Absence	85	82	85	82	85	77
	Presence	5	14	5	14	5	18
Mycoplasma hominis	Absence	100	100	100	100	100	100
	Presence	0	0	0	0	0	0
Ureaplasma urealyticum	Absence	100	100	100	100	100	100
	Presence	0	0	0	0	0	0